Evaluation of Infants Fed an Extensively Hydrolyzed Infant Formula
Public ClinicalTrials.gov record NCT03884309. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Tolerance, Compliance and Growth of Infants Fed an Extensively Hydrolyzed Infant Formula With Added Human Milk Oligosaccharides
Study identification
- NCT ID
- NCT03884309
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Abbott Nutrition
- Industry
- Enrollment
- 48 participants
Conditions and interventions
Conditions
Interventions
- Experimental Hydrolyzed Protein Infant Formula Other
Other
Eligibility (public fields only)
- Age range
- Up to 60 Days
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 24, 2019
- Primary completion
- Jan 6, 2020
- Completion
- Jan 6, 2020
- Last update posted
- Feb 4, 2020
2019 – 2020
United States locations
- U.S. sites
- 6
- U.S. states
- 5
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Paramount Research Solutions | College Park | Georgia | 30349 | — |
| Michael W. Simon, M.D., PSC | Nicholasville | Kentucky | 40356 | — |
| Midwest Children's Health Research Institute | Lincoln | Nebraska | 68522 | — |
| Memphis & Shelby County Pediatric Group | Memphis | Tennessee | 38116 | — |
| Ventavia Research Group, LLC | Houston | Texas | 77008 | — |
| DCOL Center for Clinical Research | Longview | Texas | 75605 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03884309, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 4, 2020 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03884309 live on ClinicalTrials.gov.